# A Clinical Trial of PRAX-114 in Participants With Essential Tremor

> **NCT05387642** · PHASE2 · WITHDRAWN · sponsor: **Praxis Precision Medicines**

## Conditions studied

- Essential Tremor

## Interventions

- **DRUG:** 10 mg PRAX-114, 20 mg PRAX-114, and Placebo
- **DRUG:** 10 mg PRAX-114 or 20 mg PRAX-114

## Key facts

- **NCT ID:** NCT05387642
- **Lead sponsor:** Praxis Precision Medicines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-04-05
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor no longer pursuing indication.
- **Last updated:** 2022-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05387642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05387642, "A Clinical Trial of PRAX-114 in Participants With Essential Tremor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05387642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*